Kestra Medical Technologies makes the ASSURE wearable defibrillator and a connected monitoring platform for heart patients. KMTS reports earnings on Thu, Dec 10, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 2 | BTIG | Reiterated | Buy | |
| Aug 10 | JP Morgan | Initiated | Buy |
Whale Options Flow
90DNo whale options trades in KMTS in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether KMTS is in one of them and how their past KMTS trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered KMTS in an article yet. Here's the latest on the wider market.
About Kestra Medical Technologies
Kestra Medical Technologies is a medical device and digital health company based in Kirkland, Washington. It makes the ASSURE wearable cardioverter defibrillator, which is worn by patients at elevated risk of sudden cardiac arrest during recovery from heart problems. The company also offers a connected platform with a patient app, remote monitoring software for clinicians, and alert services that notify care teams when a shock is delivered. Its customers are patients and the healthcare providers who manage their cardiac care in the United States.
- Headquarters
- Kirkland, WA